glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism The changing treatment landscape of
The changing treatment landscape of EGFR mutant non small cell lung cancer Nature Reviews Clinical Oncology The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Glutathione Dependent Pathways in Cancer Cells Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience The role of glutathione in the cellular response to cisplatin. (A) GSH Download Scientific Diagram
Pay in 4 interest-free payments of $6.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27




